GRAL surprised there is no talk about Grail. Not a new company and used to be valued at 8b when Illumina bought them years ago. They were then forced to separate them and the stock dipped to as little as 500m. Their revenue is increasing and they have a potentially game changing product for cancer. I bought in at the low and took my profit when markets seemed to be topping. We are now likely at a temporary bottom although it could be a more permanent bottom from Grail and I bought back in start of the day, now looking to hold for years.